Page last updated: 2024-10-28

hexamethonium and Hypocapnia

hexamethonium has been researched along with Hypocapnia in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Hypocapnia: Clinical manifestation consisting of a deficiency of carbon dioxide in arterial blood.

Research Excerpts

ExcerptRelevanceReference
"After saline pretreatment, response to 5-HT consisted of immediate and brief apnea, bradycardia, and hypotension, followed by sustained tachypnea, tachycardia, pulmonary hypertension, and hypocapnic hypoxemia."3.69Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves. ( Amory, H; Desmecht, DJ; Lekeux, PM; Linden, AS, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Linden, AS1
Desmecht, DJ1
Amory, H1
Lekeux, PM1

Other Studies

1 other study available for hexamethonium and Hypocapnia

ArticleYear
Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves.
    American journal of veterinary research, 1996, Volume: 57, Issue:6

    Topics: Aging; Animals; Apnea; Atropine; Bradycardia; Cattle; Cattle Diseases; Cholinergic Agents; Ganglioni

1996